Literature DB >> 658255

Inhibition of reserpine-induced PGO waves in the cat by ergot derivatives.

P E Züger, J M Vigouret, D M Loew.   

Abstract

The number of reserpine-induced PGO waves in the cat is decreased by administration of ergot derivatives. The inhibition is dose-dependent and the various ergot derivatives show differing potencies. The action of the ergot derivatives may result from stimulation of central serotonin receptors. In addition, possible involvement of dopaminergic systems is discussed.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 658255     DOI： 10.1007/BF01937007

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  19 in total

1.  Drugs and PGO waves in the lateral geniculate body of the curarized cat. V. Miscellaneous compounds. Synopsis of the role of central neurotransmitters on PGO wave activity.

Authors:  M A Ruch-Monachon; M Jalfre; W Haefely
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-02

2.  Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

Authors:  A M Johnson; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

3.  [Effects of LSD and methysergide on ponto-geniculo-occipital spikes].

Authors:  J L Froment; E Eskazan
Journal:  C R Seances Soc Biol Fil       Date:  1971-06

4.  An analysis of the effect of reserpine upon ponto-geniculo-ooccipital wave activity in the cat.

Authors:  D C Brooks; M D Gershon
Journal:  Neuropharmacology       Date:  1972-07       Impact factor: 5.250

5.  Blockade of central 5-hydroxytryptamine receptors by methiothepin.

Authors:  M A Monachon; W P Burkard; M Jalfre; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  LSD as an agonist of dopamine receptors in the striatum.

Authors:  L Pieri; M Pieri; W Haefely
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

7.  Neuropharmacological studies on hydergine.

Authors:  H Depoortere; D M Loew; J M Vigouret
Journal:  Triangle       Date:  1975

8.  Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Authors:  K Fuxe; B B Fredholm; L F Agnati; S O Ogren; B J Everitt; G Jonsson; J A Gustafsson
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

9.  Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat.

Authors:  D M Loew; H Depoortere; H R Buerki
Journal:  Arzneimittelforschung       Date:  1976

10.  Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.

Authors:  N E Andén; H Corrodi; K Fuxe; T Hökfelt
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739
View more
  2 in total

1.  Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals.

Authors:  M Yamamoto; M Shimizu; A Iwai
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Towards a Functional Understanding of PGO Waves.

Authors:  Jarrod A Gott; David T J Liley; J Allan Hobson
Journal:  Front Hum Neurosci       Date:  2017-03-03       Impact factor: 3.169
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.